中国药物与临床
中國藥物與臨床
중국약물여림상
CHINESE REMEDIES & CLINICS
2015年
4期
454-457
,共4页
董莉%王晨%史永红%韦金英%杜春阳%李宏博%吴海江%任韫卓
董莉%王晨%史永紅%韋金英%杜春暘%李宏博%吳海江%任韞卓
동리%왕신%사영홍%위금영%두춘양%리굉박%오해강%임운탁
转化生长因子β%肾小管%上皮细胞%细胞凋亡
轉化生長因子β%腎小管%上皮細胞%細胞凋亡
전화생장인자β%신소관%상피세포%세포조망
Transforming growth factor beta%Kidney tubules%Epithelial cells%Apoptosis
目的:观察沉默调节蛋白1(Sirt1)过表达对转化生长因子(TGF)-β1诱导人肾小管上皮细胞凋亡的影响及其机制研究。方法将体外培养人肾小管上皮细胞分为正常对照组、TGF-β1刺激组及TGF-β1+Sirt1过表达组。采用原位末端转移酶标记技术(TUNEL)检测细胞凋亡;流式细胞术及hoechst33258染色法分别检测细胞凋亡百分比;蛋白质印迹法检测Sirt1、结缔组织生长因子(CTGF)、Bax、Bcl-2的表达;实时荧光定量聚合酶链反应(Real time-PCR)检测Sirt1、CTGF、Bax、Bcl-2mRNA水平;活性比色法检测Sirt1活性;免疫细胞化学方法检测Sirt1表达。结果与正常对照组相比,TGF-β1刺激组肾小管上皮细胞Sirt1表达及活性均显著下降,同时CTGFmRNA及蛋白水平显著上升,细胞凋亡百分比明显增加(P<0.01),Bax/Bcl-2比率明显升高(P<0.05)。Sirt1过表达能够显著抑制TGF-β1诱导的CTGF水平升高,降低肾小管上皮细胞凋亡百分比,减少Bax/Bcl-2比率(P<0.05)。结论 Sirt1过表达能够抑制TGF-β1诱导的人肾小管上皮细胞凋亡,并且该作用的实现可能是部分通过抑制CTGF实现的。
目的:觀察沉默調節蛋白1(Sirt1)過錶達對轉化生長因子(TGF)-β1誘導人腎小管上皮細胞凋亡的影響及其機製研究。方法將體外培養人腎小管上皮細胞分為正常對照組、TGF-β1刺激組及TGF-β1+Sirt1過錶達組。採用原位末耑轉移酶標記技術(TUNEL)檢測細胞凋亡;流式細胞術及hoechst33258染色法分彆檢測細胞凋亡百分比;蛋白質印跡法檢測Sirt1、結締組織生長因子(CTGF)、Bax、Bcl-2的錶達;實時熒光定量聚閤酶鏈反應(Real time-PCR)檢測Sirt1、CTGF、Bax、Bcl-2mRNA水平;活性比色法檢測Sirt1活性;免疫細胞化學方法檢測Sirt1錶達。結果與正常對照組相比,TGF-β1刺激組腎小管上皮細胞Sirt1錶達及活性均顯著下降,同時CTGFmRNA及蛋白水平顯著上升,細胞凋亡百分比明顯增加(P<0.01),Bax/Bcl-2比率明顯升高(P<0.05)。Sirt1過錶達能夠顯著抑製TGF-β1誘導的CTGF水平升高,降低腎小管上皮細胞凋亡百分比,減少Bax/Bcl-2比率(P<0.05)。結論 Sirt1過錶達能夠抑製TGF-β1誘導的人腎小管上皮細胞凋亡,併且該作用的實現可能是部分通過抑製CTGF實現的。
목적:관찰침묵조절단백1(Sirt1)과표체대전화생장인자(TGF)-β1유도인신소관상피세포조망적영향급기궤제연구。방법장체외배양인신소관상피세포분위정상대조조、TGF-β1자격조급TGF-β1+Sirt1과표체조。채용원위말단전이매표기기술(TUNEL)검측세포조망;류식세포술급hoechst33258염색법분별검측세포조망백분비;단백질인적법검측Sirt1、결체조직생장인자(CTGF)、Bax、Bcl-2적표체;실시형광정량취합매련반응(Real time-PCR)검측Sirt1、CTGF、Bax、Bcl-2mRNA수평;활성비색법검측Sirt1활성;면역세포화학방법검측Sirt1표체。결과여정상대조조상비,TGF-β1자격조신소관상피세포Sirt1표체급활성균현저하강,동시CTGFmRNA급단백수평현저상승,세포조망백분비명현증가(P<0.01),Bax/Bcl-2비솔명현승고(P<0.05)。Sirt1과표체능구현저억제TGF-β1유도적CTGF수평승고,강저신소관상피세포조망백분비,감소Bax/Bcl-2비솔(P<0.05)。결론 Sirt1과표체능구억제TGF-β1유도적인신소관상피세포조망,병차해작용적실현가능시부분통과억제CTGF실현적。
Objective To investigate the effect of Sirt1 overexpression on TGF-β1-induced apoptosis in human kidney proximal tubular cell line (HK-2) and its mechanism. Methods Cultured HK-2 cells were divided into normal group (NG), TGF-β1(5 ng/ml) group, TGF-β1(5 ng/ml) +Sirt1 overexpression plasmid group. Apoptosis of HK-2 cells was analyzed by DeadEndTM Fluorometric TUNEL System. Meanwhile, apoptotic cell percentage was also observed by flow cytometry of Annexin V/PI staining assay and hoechst 33258 staining. The expression levels of Sirt1, CTGF, Bax, Bcl-2 were observed by western blot. The expression levels of Sirt1, CTGF, Bax, Bcl-2 mRNA were observed by real time-PCR. Sirt1deacetylase activity was colorimetrically measured by the Sirt1 deacetylase activity assay kit. Immuno-cytochemistry was used to investigate the location and level of expression of Sirt1 protein. Results Compared with NG, the expression of CTGF (P<0.01), the number of cell apoptosis (P<0.01) and ratio of Bax/Bcl-2 (P<0.05) signifi-cantly increased,while the expression and activity of Sirt1 decreased dramatically in HK-2 cells in the TGF-β1 group (P<0.01). Transfection with Sirt1 overexpression plasmid ameliorated TGF-β1-induced increase in CTGF, cell apopto-sis, ratio of Bax/Bcl-2 increase in HK-2 cells (P<0.05). Conclusion Sirt1 overexpression ameliorates TGF-β1-induced human kidney proximal tubular cell line apoptosis by inhibiting CTGF.